Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B

计划入组 20 人 · 首次发布于 2014 年 11 月 5 日

A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder

计划入组 20 人 · 首次发布于 2024 年 10 月 1 日

Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety

计划入组 30 人 · 首次发布于 2013 年 5 月 20 日

Talazoparib(Talzenna)

C₁₉H₁₄F₂N₆O

Avelumab(Bavencio)

1-b

NHI-1

United States

AB&B BIO-TECH-B

Xi'an No.1 Hospital

China

Sapu Nano's Injectable Everolimus Formulation Sapu003 Receives Approval for Phase 1 Breast Cancer Trial

CytomX Reports Promising Phase 1 Biomarker Data for CX-801 in Advanced Melanoma at SITC 2025

Immunocore's IMC-I109V Shows Promising Antiviral Activity in Phase 1 Hepatitis B Trial